EP1082459A4 - Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs - Google Patents

Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs

Info

Publication number
EP1082459A4
EP1082459A4 EP99921894A EP99921894A EP1082459A4 EP 1082459 A4 EP1082459 A4 EP 1082459A4 EP 99921894 A EP99921894 A EP 99921894A EP 99921894 A EP99921894 A EP 99921894A EP 1082459 A4 EP1082459 A4 EP 1082459A4
Authority
EP
European Patent Office
Prior art keywords
diagnosing
monitoring
lung cancer
novel method
staging lung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99921894A
Other languages
English (en)
French (fr)
Other versions
EP1082459A1 (de
Inventor
Fei Yang
Roberto A Macina
Yongming Sun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of EP1082459A1 publication Critical patent/EP1082459A1/de
Publication of EP1082459A4 publication Critical patent/EP1082459A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP99921894A 1998-05-21 1999-05-12 Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs Withdrawn EP1082459A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8621298P 1998-05-21 1998-05-21
US86212P 1998-05-21
PCT/US1999/010344 WO1999060160A1 (en) 1998-05-21 1999-05-12 A novel method of diagnosing, monitoring, and staging lung cancer

Publications (2)

Publication Number Publication Date
EP1082459A1 EP1082459A1 (de) 2001-03-14
EP1082459A4 true EP1082459A4 (de) 2002-09-25

Family

ID=22197037

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99921894A Withdrawn EP1082459A4 (de) 1998-05-21 1999-05-12 Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs

Country Status (4)

Country Link
EP (1) EP1082459A4 (de)
JP (1) JP3688585B2 (de)
CA (1) CA2328138A1 (de)
WO (1) WO1999060160A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130182A1 (en) * 1997-11-05 2003-07-10 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US7291712B2 (en) 1998-06-25 2007-11-06 Genentech, Inc. Interleukin-8 homologous polypeptides and therapeutic uses thereof
JP3524061B2 (ja) * 1998-08-04 2004-04-26 ダイアデクスアス・インコーポレーテッド 肺がんを診断し、モニターし、病期決定し、画像化し、そして処置する新規な方法
EP1109937B1 (de) * 1998-09-02 2008-11-05 Diadexus, Inc. Verfahren zur diagnose, bewertung sowie bilddarstellung verschiedener krebserkrankungen
US20020004206A1 (en) * 1999-04-09 2002-01-10 Berger Barry M. Methods of screening for disease
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
WO2001053349A2 (en) * 2000-01-21 2001-07-26 Ludwig Institute For Cancer Research Small cell lung cancer associated antigens and uses therefor
WO2001061055A2 (en) * 2000-02-17 2001-08-23 Diadexus, Inc. Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
US20020119156A1 (en) * 2000-03-29 2002-08-29 Sei-Yu Chen Compositions and methods of diagnosing, monitoring, staging, imaging and treating lung cancer
US20030022257A1 (en) * 2000-07-21 2003-01-30 Macina Roberto A. Compositions and methods relating to lung specific genes
EP1328635A2 (de) * 2000-08-28 2003-07-23 Diadexus, Inc. Zusammensetzungen und verfahren mit bezug zu lungenspezifischen genen
EP1356038A2 (de) * 2000-10-26 2003-10-29 Diadexus, Inc. Zusammensetzungen und verfahren bezüglich lungen-spezifischen gene und proteine
WO2002068633A2 (en) * 2000-11-22 2002-09-06 Diadexus, Inc. Compositions and methods relating to lung specific genes and proteins
EP1873245A1 (de) * 2001-02-28 2008-01-02 Genentech, Inc. Interleukin-8-homologe Polypeptide und ihre therapeutische Verwendung
EP1453977B1 (de) * 2001-08-16 2009-11-18 THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services Molekulare eigenschaften von nichtkleinzelligem lungenkrebs
DE10254601A1 (de) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
WO2006013012A2 (en) * 2004-08-04 2006-02-09 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with napsin 1 (nap1)
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
EP2360279A1 (de) 2005-04-14 2011-08-24 Trustees Of Boston University Diagnose für Lungenerkrankungen mittels Klassenvorhersage
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
US20090061454A1 (en) 2006-03-09 2009-03-05 Brody Jerome S Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
WO2009039457A1 (en) 2007-09-19 2009-03-26 The Trustees Of Boston University Identification of novel pathways for drug development for lung disease
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
EP2968988A4 (de) 2013-03-14 2016-11-16 Allegro Diagnostics Corp Verfahren zur bewertung eines copd-status
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
EP3770274A1 (de) 2014-11-05 2021-01-27 Veracyte, Inc. Systeme und verfahren zur diagnose von idiopathischer pulmonaler fibrose auf transbronchialen biopsien mit maschinellem lernen und hochdimensionalen transkriptionsdaten
WO2018009915A1 (en) 2016-07-08 2018-01-11 Trustees Of Boston University Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039419A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Colon specific genes and proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939265A (en) * 1996-11-05 1999-08-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
CA2279551A1 (en) * 1997-01-31 1998-08-06 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
US6203979B1 (en) * 1998-01-16 2001-03-20 Incyte Pharmaceuticals, Inc. Human protease molecules
WO2000000610A2 (en) * 1998-06-26 2000-01-06 Incyte Pharmaceuticals, Inc. Human signal peptide-containing proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996039419A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Colon specific genes and proteins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE [online] March 1998 (1998-03-01), WANG Z ET AL: "[Expression and prognostic relation of cathepsin D in non-small cell lung cancer tissues and lymph nodes]", XP002206076, Database accession no. NLM11263354 *
See also references of WO9960160A1 *
ZHONGHUA JIE HE HE HU XI ZA ZHI = CHINESE JOURNAL OF TUBERCULOSIS AND RESPIRATORY DISEASES. CHINA MAR 1998, vol. 21, no. 3, March 1998 (1998-03-01), pages 164 - 166, ISSN: 1001-0939 *

Also Published As

Publication number Publication date
CA2328138A1 (en) 1999-11-25
JP2002515262A (ja) 2002-05-28
WO1999060160A1 (en) 1999-11-25
JP3688585B2 (ja) 2005-08-31
EP1082459A1 (de) 2001-03-14

Similar Documents

Publication Publication Date Title
EP1082459A4 (de) Neue methode zur diagnose, überwachung und bestimmung des stadiums von lungenkrebs
EP1105528A4 (de) Verfahren zur diagnose, überwachung, klassifizierung, bildgebungund behandlung von brustkrebs
GB2302892B (en) Downhole gas compressor
GB2286844B (en) Wellbore monitoring apparatus
GB9502968D0 (en) Coalbed drilling
GB2347445B (en) Drilling method
GB2340152B (en) Multiple string completion apparatus and method
GB2303706B (en) Lung function monitoring apparatus flowheads
EP1123102A4 (de) Methoden zur verhinderung von akuten lungenverletzungen
GB9925449D0 (en) Well logging apparatus and method
HUP9903857A3 (en) Method for the production of curved glazing
GB2344123B (en) Well logging method and apparatus
IL126731A0 (en) A method of detection
GB2310678B (en) Packer, packer assembly and method for a wellbore
GB2313610B (en) Method of performing a downhole operation
GB2380213B (en) Apparatus including a wellbore and wellbore casing
EP1104486A4 (de) Neues verfahren zur diagnose, zur verlaufsbeobachtung und zum abbilden von lungenkrebs
GB9701612D0 (en) Downhole production well instrumentation
EP1267934A4 (de) Neues verfahren zur diagnose, überwachung, statusbestimmung, bildmässiger darstellung und behandlung von brustkrebs
EP1107798A4 (de) Neues verfahren zur diagnose, überwachung, klassifizierung, bildgebung und behandlung von kolonkrebs
EP1082460A4 (de) Neuartiges verfahren zur diagnose, zur überwachung und verlaufsbeobachtung von prostatakrebs
GB9820919D0 (en) Diagnostic method
GB9807051D0 (en) Monitoring arrangement and method
GB9822767D0 (en) Drilling method
GB9805775D0 (en) Method for forming a casing window

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001221

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIADEXUS, INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIADEXUS, INC.

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12Q 1/68 A, 7G 01N 33/72 B, 7G 01N 33/574 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020809

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20021029

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050504